相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The treatment of resectable gastric cancer: a literature review of an evolving landscape
Iris Tung et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)
Oncolytic virus: A catalyst for the treatment of gastric cancer
Junqing Wang et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
Sara A. Collins et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors
Shuji Kubo et al.
CANCER GENE THERAPY (2019)
Update on gastric cancer treatments and gene therapies
Alessio Biagioni et al.
CANCER AND METASTASIS REVIEWS (2019)
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Shuji Kubo et al.
CANCER GENE THERAPY (2019)
The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells
Ryutaro Mori et al.
GASTRIC CANCER (2019)
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
Kazuho Inoko et al.
CANCER GENE THERAPY (2018)
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
Daniel J. Hogan et al.
CLINICAL CANCER RESEARCH (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection
Spyridon Stavrou et al.
MBIO (2018)
Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
W. Zhou et al.
GENE THERAPY (2017)
Natural killer T cells contribute to the control of acute retroviral infection
Elisabeth Littwitz-Salomon et al.
RETROVIROLOGY (2017)
A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter
Kyong-Hwa Jun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines
A. Q. Butt et al.
ONCOGENE (2014)
Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus
S. Kubo et al.
CANCER GENE THERAPY (2013)
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer
Toshiaki Tsuji et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow
Giovanni Biasi et al.
IMMUNOLOGY LETTERS (2011)
The receptors for gibbon ape leukemia virus and amphotropic murine leukemia virus are not downregulated in productively infected cells
Meihong Liu et al.
RETROVIROLOGY (2011)
Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors
Clare Jolly
VIROLOGY (2011)
The interface between the innate interferon response and expression of host retroviral restriction factors
Renee N. Douville et al.
CYTOKINE (2010)
Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model
Koji Kawaguchi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
Kyo Young Song et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Shruthi Naik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer
Erin S. Haley et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Host factors involved in resistance to retroviral infection
Hiroaki Takeuchi et al.
MICROBIOLOGY AND IMMUNOLOGY (2008)
Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma
CK Tai et al.
MOLECULAR THERAPY (2005)
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model
MK Nyati et al.
GENE THERAPY (2002)
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins
J Overbaugh et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
分享论文
